David Katz Downgraded (CCL) to Sell and Increased Target to $33 on, Feb 11th, 2014
David has made no other calls on CCL in the last 4 months.
There are 4 other peers that have a rating on CCL. Out of the 4 peers that are also analyzing CCL, 2 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Patrick Scholes of "SunTrust Robinson Humphrey" Upgraded from Sell to Hold on, Monday, January 13th, 2014
- Harry Curtis of "Nomura" Maintained at Hold with Increased Target to $36 on, Friday, December 20th, 2013
These are the ratings of the 2 analyists that currently disagree with David
- Ali Naqvi of "HSBC" Upgraded from Hold to Buy and Increased Target to $44 on, Wednesday, February 5th, 2014
- Benjamin Chaiken of "Credit Suisse" Upgraded from Hold to Buy and Increased Target to $43 on, Friday, December 20th, 2013
on: Wed, Feb 05th 2014
by: WOPRAI
Ali Naqvi Upgraded (CCL) to Buy and Increased Target to $44 on, Feb 5th, 2014
on: Mon, Jan 13th 2014
by: WOPRAI
on: Fri, Dec 20th 2013
by: WOPRAI
Harry Curtis Maintained (CCL) at Hold with Increased Target to $36 on, Dec 20th, 2013
on: Fri, Dec 20th 2013
by: WOPRAI
Benjamin Chaiken Upgraded (CCL) to Buy and Increased Target to $43 on, Dec 20th, 2013
on: Fri, Oct 04th 2013
by: WOPRAI
Patrick Scholes Initiated (CCL) at Sell and Held Target at $26 on, Oct 4th, 2013
on: Wed, Sep 04th 2013
by: WOPRAI
Christopher Stathoulopoulos Upgraded (CCL) to Buy on, Sep 4th, 2013
on: Wed, Mar 13th 2013
by: WOPRAI
James Fotheringham Initiated (WFC) at Hold and Held Target at $40 on, Mar 13th, 2013
on: Mon, Feb 25th 2013
by: WOPRAI
Benjamin Chaiken Maintained (CCL) at Hold with Decreased Target to $35 on, Feb 25th, 2013
on: Fri, Feb 22nd 2013
by: WOPRAI
Eric Wasserstrom Upgraded (V) to Strong Buy on, Feb 22nd, 2013
on: Thu, Feb 07th 2013
by: WOPRAI
on: Wed, Jan 09th 2013
by: WOPRAI
Daniel Fannon Maintained (TROW) at Strong Buy with Increased Target to $78 on, Jan 9th, 2013
on: Mon, Dec 24th 2012
by: WOPRAI
Stephen Grambling Maintained (CCL) at Hold with Decreased Target to $39 on, Dec 24th, 2012